Arkolith/Insider Trading/TPST/Form 4

Versant Venture Capital VI, L.P.

10% OwnerTempest Therapeutics, Inc. (TPST) · full profile →Form 4 · filed Aug 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$967K
Net Open-Market Flow
-$967K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2024Sell(S)388K$1.10$427K210K
Aug 8, 2024Sell(S)400K$1.35$540K598K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-095675) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML